Carcinogenesis: Basic principles

Drug and Chemical Toxicology

Volumn 19, Issue 3, 1996, Pages 133-148

  Couch, David B ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; AZO DYE; CARCINOGEN; CIGARETTE SMOKE; NITROSO DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; BIOTRANSFORMATION; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; DNA REPAIR; DOSE RESPONSE; HUMAN; MOUSE; NONHUMAN; RAT; REVIEW; TUMOR PROMOTION;

ANIMALIA;

EID: 0029914769     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549608998231     Document Type: Review

References (54)

1. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. (1994). Molecular Biology of the Cell, 3rd ed., Garland Publishing, New York, pp. 863-910.
2. Barnes, D. E., Lindahl, T., and Sedgwick, B. (1993). DNA repair, Curr. Opinion Cell Biol., 5, 424-433.
3. Barrett, J. C. (1992). Mechanism of action of known human carcinogens. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, et al., eds.), IARC, Lyon, France, pp. 115-134.
4. Beckman, R. A., Mildvan, A. S., and Loeb, L. A. (1985). On the fidelity of DNA replication: Manganese mutagenesis in vitro, Biochemistry, 24, 5810-5817.
5. Borek, C. (1993). Molecular mechanisms in cancer induction and prevention, Environ. Health Perspect., 101 (Suppl. 3), 237-245.
6. Boylan, M. O. and Zarbl, H. (1991). Transformation effector and suppressor genes, J. Cell. Biochem., 46, 199-205.
7. Cairns, J. (1981). The origin of human cancers, Nature, 289, 353-357.
8. Castagna, M. (1987). Phorbol esters as signal transducers and tumor promoters, Biol. Cell, 59, 3-13.
9. Cheng, K. C. and Loeb, L. A. (1993). Genomic instability and tumor progression: mechanistic considerations, Adv. Cancer Res., 60, 121-156.
10. Cleaver, J. E. (1994). It was a very good year for DNA repair, Cell, 76, 1-4.
11. Cohen, S. M. and Ellwein, L. B. (1991). Genetic errors, cell proliferation, and carcinogenesis, Cancer Res., 51, 6493-6505.
12. Cooper, G. M. (1990). Oncogenes, Jones and Bartlett, Boston.
13. Crawford, B. D. (1985). Perspectives on the somatic mutation model of carcinogenesis. In Advances in Modern Environmental Toxicology, Vol. 12 (M.A. Mehlman, ed.), Princeton Scientific Publishing, Princeton, pp. 13-59.
14. Duesberg, P. H., Goodrich, D., and Zhou, R.-P. (1991). Cancer genes by non-homologous recombination. In Boundaries between Promotion and Progression During Carcinogenesis (O. Sudilovsky, et al., eds.), Plenum Press, New York, pp. 197-211.
15. Dunlop, M. G. (1991). Allele losses and onco-suppressor genes, J. Pathol., 163, 1-5.
16. Ehrenberg, L., Moustacchi, E., and Osterman-Golkar, S. (1983). Dosimetry of genotoxic agents and dose-response relationship of their effects, Mutat. Res., 123, 121-182.
17. El-Bayoumy, K. (1994). Evaluation of chemopreventive against breast cancer and proposed strategies for future clinical intervention trials, Carcinogenesis, 15, 2395-2420.
18. Eling, T. E., Thompson, D. C., Foureman, G. L., Curtis, J. F., and Hughes, M. F. (1990). Prostaglandin H synthase and xenobiotic oxidation, Annu. Rev. Pharmacol. Toxicol., 30, 1-45.
19. Epstein, R. J. (1986). Is your initiator really necessary? J. Theor. Biol., 122, 359-374.
20. Farber, E. (1984). The multistep nature of cancer development, Cancer Res., 44, 4217-4223.
21. Gibson, G. G. (1993). Peroxisome proliferators: Paradigms and prospects, Toxicol. Lett., 68, 193-201.
22. Hanawalt, P. C., Donahue, B. A., and Sweder, K. S. (1994). Repair and transcription: collision or collusion? Curr. Biol., 4, 518-521.
23. Harrington, E. A., Fanidi, A., and Evan, G. I. (1994). Oncogenes and cell death, Curr. Opinion Genet. Dev., 4, 120-129.
24. Harris, C. C. (1991). Chemical and physical carcinogenesis: Advances and perspectives for the 1990s, Cancer Res., 51 (Suppl.), 5023s-5044s.
25. Hecht, S. S., el-Bayoumy, K., Rivenson, A., and Amin, S. (1994). Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene, Cancer Res., 54, 21-24.
26. Heddle, J. A., Krepinsky, A. B., and Marshall, R. R. (1983). Cellular sensitivity of mutagens and carcinogens in the chromosome-breakage and other cancer-prone syndromes. In Chromosome Mutation and Neoplasia, Alan R. Liss, New York, pp. 203-234.
27. Hennings, H., Glick, A. B., Greenhalgh, D. A., Morgan, D. L., Strickland, J. E., Tennenbaum, T., and Yuspa, S. H. (1993). Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis, Proc. Soc. Exp. Biol. Med., 202, 1-8.
28. Hochberg, A., Gonik, B., Goshen, R., and de Groot, N. (1994). A growing relationship between genomic imprinting and tumorigenesis, Cancer Genet. Cytogenet., 73, 82-83.
29. Holliday, R. (1987). The inheritance of epigenetic defects, Science, 238, 163-170.
30. Huff, J., Cirvello, J., Haseman, J., and Bucher, J. (1991). Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents, Environ. Health Perspect., 93, 247-270.
31. [IARC] International Agency for Cancer Research (1987). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs Vols. 1-48, IARC, Lyon, France.
32. [IARC] International Agency for Research on Cancer (1992). Consensus report. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, et al., eds.), IARC, Lyon, France, pp. 9-54.
33. Idle, J. R., Armstrong, M., Boddy, A. V., Boustead, C., Cholerton, S., Cooper, J., Daly, A. K., Ellis, J., Gregory, W., Hadidi, H., Hofer, C., Holt, J., Leathart, J., McCracken, N., Monkman, S. C., Painter, J. E., Taber, H., Walker, D., and Yule, M. (1992). The pharmacogenetics of chemical carcinogenesis, Pharmacogenetics, 2, 246-258.
34. Knudson, A. G. (1993). Antioncogenes and human cancer, Proc. Natl. Acad. Sci. USA, 90, 10914-10921.
35. Lieberman, M. W. and Lebovitz, R. M. (1990). Neoplasia. In Anderson's Pathology, Vol. 1 (J. M. Kissane, Ed.), C. V. Mosby. St. Louis, MO, pp. 566-614.
36. Liotta, L. A. and Stetler-Stevenson, W. G. (1991). Tumor invasion and metastasis: An imbalance of positive and negative regulation, Cancer Res., 51(Suppl.), 5054s-5059s.
37. Lu, F. C. 1991). Carcinogenesis. In Basic Toxicology: Fundamentals, Target Organs, and Risk Assessment, Hemisphere Publishing, Washington, DC, pp. 93-115.
38. Melnick R. L., Huff, J., Barrett, J. C., Maronpot, R. R., Lucier, G., and Portier, C. F. (1993). Cell proliferation and chemical carcinogenesis: Symposium overview. Environ Health Perspect., 101(Suppl. 5), 3-7.
39. Miller, E. C. and Miller, J. A. (1981). Mechanisms of chemical carcinogenesis, Cancer, 47, 1005-1064.
40. Murray, A. and Hunt, T. (1993). The Cell Cycle. An Introduction, W. H. Freeman, New York.
41. Nowell, P. C. (1991). Genetic instability and tumor development. In Boundaries Between Promotion and Progression During Carcinogenesis (O. Sudilovsky, et al., eds.), Plenum Press, New York, pp. 221-231.
42. Peter, M. and Herskowitz, I. (1994). Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle, Cell, 19, 181-184.
43. Pitot, H. C., Dragan, Y., Xu, Y.-H., Peterson, J., Hully, J., and Campbell, H. (1992). Pathways of carcinogenesis - genetic and epigenetic. In Multistage Carcinogenesis (C. C. Harris, et al., eds.), CRC Press, Boca Raton, FL, pp. 21-33.
44. Rabbitts, T. H. (1994). Chromosome translocations in human cancer, Nature, 372, 143-149.
45. Rubin, H. (1985). Cancer as a dynamic developmental disorder, Cancer Res., 45, 2935-2942.
46. Sancar, A. and Tang, M.-S. (1993). Nucleotide excision repair, Photochem. Photobiol., 57, 905-921.
47. Shields, P. G. and Harris, C. C. (1991). Molecular epidemiology and the genetics of environmental cancer, JAMA, 266, 681-687.
48. Sugimura, T. and Wakabayashi, K. (1990). Mutagens and carcinogens in food. In Mutagens and Carcinogens in the Diet (M. W. Pariza, et al., eds.), Wiley-Liss, New York, pp. 1-18.
49. Sulitzeanu, D. (1993). Immunosuppressive factors in human cancer, Adv. Cancer Res., 60, 247-267.
50. Swenberg, J. A., Dietrich, D. R., McClain, R. M., and Cohen, S. M. (1992). Species-specific mechanisms of carcinogenesis. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, et al., eds.), IARC, Lyon, France, pp. 477-500.
51. Vasiliev, J. M. (1983). Cell microenvironment and carcinogenesis in vivo and in vitro, IARC Sci. Publ., 51, 247-256.
52. Weisburger, J. H. (1994a). Practical approaches to chemoprevention of cancer, Drug Metab. Rev., 26, 253-260.
53. Weisburger, J. H. (1994b). Environmental hazards, lifestyle and disease prevention, J. Hazard. Mater., 39, 129-133.
54. Williams, G. M. and Weisburger, J. H. (1991). Chemical carcinogenesis. In Casarett and Doull's Toxicology. The Basic Science of Poisons (M. O. Amdur, et al., eds.), McGraw-Hill, New York, pp. 127-200.